Figure 6.
Survival curves among 77 patients with relapsed T-NHL treated with BV in second- and third-line. (A) 5-year OS and PFS curves are presented. (B) The 5-year OS curves according to response outcome are presented.
Survival curves among 77 patients with relapsed T-NHL treated with BV in second- and third-line. (A) 5-year OS and PFS curves are presented. (B) The 5-year OS curves according to response outcome are presented.
